Adjusted EBITDA grew 5% to $293 million with margin expansion, despite a 3% decline in contract sales due to VPG moderation and execution issues. Full-year EBITDA guidance is maintained, with cost discipline and strategic actions expected to offset near-term sales pressures.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.